Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1974 Aug;54(2):477–485. doi: 10.1172/JCI107783

Pure Human Big Gastrin IMMUNOCHEMICAL PROPERTIES, DISAPPEARANCE HALF TIME, AND ACID-STIMULATING ACTION IN DOGS

John H Walsh 1,2, Haile T Debas 1,2, Morton I Grossman 1,2
PMCID: PMC301575  PMID: 4847254

Abstract

Biological properties of pure natural human “big gastrin” (designated G-34 because it contains 34 amino acid residues) were compared with those of pure natural heptadecapeptide gastrins (G-17) from human and porcine sources. Radioimmunoassay inhibition curves indicated that G-17 was nearly 1.5 times more potent than G-34 with the antibody used in this study. This difference was confirmed by demonstration of increased immunoreactivity generated when G-34 was converted to G-17 by trypsinization.

When infused intravenously into dogs with gastric fistulas and Heidenhain pouches in equimolar doses, G-34 produced slightly higher acid secretory responses than G-17. Responses to sulfated and nonsulfated forms were not significantly different, nor were responses to human and porcine G-17.

During infusion of equimolar doses, steady-state serum gastrin concentrations were more than fivefold higher with G-34 than with G-17. The difference in steady-state blood concentrations could be accounted for by a corresponding difference in removal rates. The half times of the G-34 preparations averaged 15.8 min and the half times of the G-17 preparations averaged 3.2 min. The calculated spaces of distribution for G-17 and G-34 were similar, about 25% of body weight.

When the increment in serum gastrin was plotted against acid secretory response it was found that nearly five times greater increments in molar concentrations of G-34 than of G-17 were required to produce the same rate of acid secretion. The potency of these two molecular forms of gastrin can be expressed in two different ways. Based on exogenous molar doses, the potencies of G-34 and G-17 were similar. However, based on molar increments in serum gastrin concentration, G-17 was approximately five times more potent than G-34. Hence, fractionation of these gastrin components may be important in estimation of the acid-stimulating action represented by total serum gastrin as measured by radio-immunoassay.

Full text

PDF
477

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berson S. A., Yllow R. S. Nature of immunoreactive gastrin extracted from tissues of gastrointestinal tract. Gastroenterology. 1971 Feb;60(2):215–222. [PubMed] [Google Scholar]
  2. DODGSON K. S., ROSE F. A., TUDBALL N. Studies on sulphatases. 23. The enzymic desulphation of tyrosine O-sulphate. Biochem J. 1959 Jan;71(1):10–15. doi: 10.1042/bj0710010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. GREGORY R. A. Gastric secretory responses after portal venous ligation. J Physiol. 1958 Nov 10;144(1):123–137. doi: 10.1113/jphysiol.1958.sp006090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. GREGORY R. A., TRACY H. J. THE CONSTITUTION AND PROPERTIES OF TWO GASTRINS EXTRACTED FROM HOG ANTRAL MUCOSA. Gut. 1964 Apr;5:103–114. [PMC free article] [PubMed] [Google Scholar]
  5. Gregory R. A., Tracy H. J., Agarwal K. L., Grossman M. I. Aminoacid constitution of two gastrins isolated from Zollinger-Ellison tumour tissue. Gut. 1969 Aug;10(8):603–608. doi: 10.1136/gut.10.8.603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gregory R. A., Tracy H. J. Isolation of two "big gastrins" from Zollinger-Ellison tumour tissue. Lancet. 1972 Oct 14;2(7781):797–799. doi: 10.1016/s0140-6736(72)92151-4. [DOI] [PubMed] [Google Scholar]
  7. Isenberg J. I., Walsh J. H., Passaro E., Jr, Moore E. W., Grossman M. I. Unusual effect of secretin on serum gastrin, serum calcium, and gastric acid secretion in a patient with suspected Zollinger-Ellison syndrome. Gastroenterology. 1972 Apr;62(4):626–631. [PubMed] [Google Scholar]
  8. McGuigan J. E., Isaza J., Landor J. H. Relationships of gastrin dose, serum gastrin, and acid secretion. Gastroenterology. 1971 Nov;61(5):659–666. [PubMed] [Google Scholar]
  9. McGuigan J. E., Trudeau W. L. Studies with antibodies to gastrin. Radioimmunoassay in human serum and physiological studies. Gastroenterology. 1970 Feb;58(2):139–150. [PubMed] [Google Scholar]
  10. Reeder D. D., Jackson B. M., Brandt E. N., Jr, Thompson J. C. Rate and pattern of disappearance of exogenous gastrin in dogs. Am J Physiol. 1972 Jun;222(6):1571–1574. doi: 10.1152/ajplegacy.1972.222.6.1571. [DOI] [PubMed] [Google Scholar]
  11. Rehefeld J. F. Three components of gastrin in human serum. Gel filtration studies on the molecular size of immunoreactive serum gastrin. Biochim Biophys Acta. 1972 Dec 28;285(2):364–372. [PubMed] [Google Scholar]
  12. Rehfeld J. F., Stadil F. Gel filtration studies on immunoreactive gastrin in serum from Zollinger-Ellison patients. Gut. 1973 May;14(5):369–373. doi: 10.1136/gut.14.5.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rehfeld J. F., Stadil F., Rubin B. Production and evaluation of antibodies for the radioimmunoassay of gastrin. Scand J Clin Lab Invest. 1972 Oct;30(2):221–232. doi: 10.3109/00365517209081114. [DOI] [PubMed] [Google Scholar]
  14. Schrumpf E., Semb L. S. The metabolic clearance rate and half-life of synthetic human gastrin in dogs. Scand J Gastroenterol. 1973;8(3):203–207. [PubMed] [Google Scholar]
  15. Stern D. H., Walsh J. H. Gastrin release in postoperative ulcer patients: evidence for release of duodenal gastrin. Gastroenterology. 1973 Mar;64(3):363–369. [PubMed] [Google Scholar]
  16. Straus E., Yalow R. S. Studies on the distribution and degradation of heptadecapeptide, big, and big big gastrin. Gastroenterology. 1974 May;66(5):936–943. [PubMed] [Google Scholar]
  17. Walsh J. H., Csendes A., Grossman M. I. Effect of truncal vagotomy on gastrin release and Heidenhain pouch acid secretion in response to feeding in dogs. Gastroenterology. 1972 Oct;63(4):593–600. [PubMed] [Google Scholar]
  18. Yalow R. S., Berson S. A. Further studies on the nature of immunoreactive gastrin in human plasma. Gastroenterology. 1971 Feb;60(2):203–214. [PubMed] [Google Scholar]
  19. Yalow R. S., Berson S. A. Radioimmunoassay of gastrin. Gastroenterology. 1970 Jan;58(1):1–14. [PubMed] [Google Scholar]
  20. Yalow R. S., Berson S. A. Size and charge distinctions between endogenous human plasma gastrin in peripheral blood and heptadecapeptide gastrins. Gastroenterology. 1970 May;58(5):609–615. [PubMed] [Google Scholar]
  21. Yalow R. S., Wu N. Additional studies on the nature of big big gastrin. Gastroenterology. 1973 Jul;65(1):19–27. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES